Immunic, Inc.

IMUXCIK 0001280776 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 22, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0003

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 28, 20267.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits May 27, 20265.02 · Departure/Election7.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits May 19, 2026no items parsed May 13, 2026no items parsed Apr 28, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Immunic, Inc.

Name	Roles	Filings
Whaley Glenn	Officer	14
Nash Duane	OfficerDirector	12
Vitt Daniel	OfficerDirector	11
Muehler Andreas	Officer	10
Neermann Joerg	Director	6

Showing 1-5 of 15

Per pagePage 1 of 3Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Immunic, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Whaley Glenn	4	75%	+10.8%	+6.1%	+31.3%	-0.2%
2	Vitt Daniel	4	75%	+8.8%	+3.1%	+31.3%	-2.3%

All filings

84 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 20, 2025	Whaley Glenn Chief Financial Officer	Holdings only	-	-	-
Jun 20, 2025	Tardio Jason President and COO	PPurchase	12,512	$0.79	$9,884
Jun 16, 2025	Nash Duane Executive Chairman · Director	PPurchase	20,000	$0.8347	$16,694
Jun 9, 2025	Muehler Andreas Chief Medical Officer	Holdings only	-	-	-
Jun 9, 2025	Phillips Barclay A Director	Holdings only	-	-	-

Showing 11-15 of 84

Per pagePrevPage 3 of 17Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value